Parag Goyal
Weill Medical College of Cornell University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Parag Goyal as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:40 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07298993 · Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)Weill Medical College of Cornell University · enrolling by invitation · Heart Failure, HFpEF, HFpEF - Heart Failure With Preserved Ejection Fraction · principal investigator
- Ph4NCT07252310 · Pilot Study of StudyU for N-of-1 Trials in HFrEF Patients (N-of-1 App)Weill Medical College of Cornell University · enrolling by invitation · HFrEF - Heart Failure With Reduced Ejection Fraction, Heart Failure, Heart Failure, Systolic · principal investigator
- N/ANCT06994325 · Testing the CHAT Program for Patients With Heart FailureWeill Medical College of Cornell University · completed · HFpEF - Heart Failure With Preserved Ejection Fraction · principal investigator
- N/ANCT05865197 · Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHFSensorum Health Inc. · unknown · CHF, Congestive Heart Failure · principal investigator
- Ph4NCT05585125 · A Preliminary Study for INFORMEDWeill Medical College of Cornell University · recruiting · Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction · principal investigator
- Ph4NCT05019027 · N-of-1 for Beta-Blockers in Cardiac AmyloidosisWeill Medical College of Cornell University · completed · Cardiac Amyloidosis, Heart Diseases, TTR Cardiac Amyloidosis · principal investigator
- Ph4NCT04767061 · Impact of Beta-blockers on Physical Function in HFpEFWeill Medical College of Cornell University · completed · Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction · principal investigator
- Ph4NCT04757584 · Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEFWeill Medical College of Cornell University · completed · Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- DEPRESCRIBE-HFPEFR01AG091005 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · fiscal years 2025 to 2026 · $680,686 awarded in 2026Grant number is on one of their registry trials
- Preventing Myocardial Events of Aging: A PREVENTABLE Ancillary StudyR01AG085420 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · fiscal years 2024 to 2026 · $706,946 awarded in 2026Same name and institution; not confirmed by an ID
- A Novel Deprescribing Intervention for Heart Failure with Preserved Ejection Fraction (HFpEF): A Prototype for Older Adults with Multimorbidity and PolypharmacyK76AG064428 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · fiscal years 2020 to 2024 · $212,756 awarded in 2024Grant number is on one of their registry trials
- Advancing the Conversations Helpful for Awareness of Illness Trajectory (CHAT) InterventionR21AG077092 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · fiscal years 2023 to 2024 · $255,403 awarded in 2024Grant number is on one of their registry trials
- Impact of Polypharmacy on Rehospitalization in Older Adults with Heart FailureR03AG056446 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · fiscal years 2017 to 2018 · $125,040 awarded in 2018Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Adapting the ShedMEDS Deprescribing Intervention to Dementia Care in Assisted LivingR24AG064025 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI CYNTHIA Melinda BOYD, MICHAEL A. STEINMAN · fiscal years 2019 to 2023Named on NCT05019027
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:40 UTC. The ranking covers the 200 most relevant of 37 PubMed records, and a shared surname and initials can bring in a namesake. All 37 on PubMed
- Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.Am J Respir Crit Care Med · 2018185 citationsRCR 9.1
- Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial.J Gastroenterol Hepatol · 202184 citationsRCR 7.0
- Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet versus traditional dietary advice for functional dyspepsia: a randomized controlled trial.J Gastroenterol Hepatol · 202271 citationsRCR 7.9
- Mentored simulation training improves procedural skills in cardiac catheterization: a randomized, controlled pilot study.Circ Cardiovasc Interv · 201270 citationsRCR 2.8
- Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study.Int J Chron Obstruct Pulmon Dis · 201457 citationsRCR 2.4
- 50 citationsRCR 3.3
- Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.Kidney Int · 201943 citationsRCR 2.7
- An evaluation of the efficacy of licorice gargle for attenuating postoperative sore throat: a prospective, randomized, single-blind study.Anesth Analg · 200941 citationsRCR 2.0
- Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohort.Eur J Heart Fail · 202241 citationsRCR 3.0
- Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial.JAMA Cardiol · 202536 citationsRCR 8.9